Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-29T19:06:43.512Z Has data issue: false hasContentIssue false
  • English
  • Français

Two Concerns about the Medicalization of Love

Published online by Cambridge University Press:  14 September 2015

MARTIN O’REILLY
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments and Columns
Information
Cambridge Quarterly of Healthcare Ethics , Volume 24 , Issue 4 , October 2015 , pp. 490 - 492
Copyright
Copyright © Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Notes

1. Earp, BD, Sandberg, A, Savulescu, J. The medicalization of love. Cambridge Quarterly of Healthcare Ethics 2015;24:323–36.CrossRefGoogle ScholarPubMed

2. See note 1, Earp et al. 2015, at 331.

3. Gupta, K. Protecting sexual diversity: Rethinking the use of neurotechnological interventions to alter sexuality. AJOB: Neuroscience 2012;3(3):4.Google Scholar

4. Angell, M. The truth about the drug companies. New York Review of Books 2004 July 15Google Scholar; available at http://www.nybooks.com/articles/archives/2004/jul/15/the-truth-about-the-drug-companies/ (last accessed 14 Aug 2014).

5. Jorgensen, PD. Pharmaceuticals, political money, and public policy: A theoretical and empirical agenda. Journal of Law, Medicine and Ethics 2013;14(3):562.Google Scholar

6. In considering initial prospects for change, Jorgensen, for example, has proposed “an agenda that would provide (a) a theoretical framework . . . with which to view pharmaceutical political power and (b) two empirical projects to document links between political money and pharmaceutical policy”; see note 5, Jorgensen 2013, at 565.

7. Cage, F, Herman, T, Good, N. Lesbian, gay, bisexual and transgender rights around the world. The Guardian 2014 May 17Google Scholar; available at http://www.theguardian.com/world/ng-interactive/2014/may/-sp-gay-rights-world-lesbian-bisexual-transgender (last accessed 19 Aug 2014).

8. Earp, BD, Sandberg, A, Savulescu, J. Brave new love: The threat of high-tech “conversion” therapy and the bio-oppression of sexual minorities. AJOB: Neuroscience 2014;5(1):4–12.Google ScholarPubMed

9. Singer, P. One World: The Ethics of Globalization. New Haven, CT: Yale University Press; 2002.Google Scholar

10. Buchanan, A. Better than Human: The Promise and Perils of Enhancing Ourselves. Oxford, New York: Oxford University Press; 2011, at 144.Google Scholar